Miguel Hernán Vicco

Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease

Iván Bontempi, Miguel Hernán Vicco, Gabriel Cabrera et al. · Vaccine · 2015 · 45 citations

Vaccinology, Vaccination, Vaccine Development +8

Trans-sialidase-based vaccine candidate protects against <i>Trypanosoma cruzi</i> infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype

Estefanía Prochetto, Carolina Roldán, Iván Bontempi et al. · Oncotarget · 2017 · 33 citations · Full text

Trans-Sialidase Overcomes Many Antigens to be Used as a Vaccine Candidate Against <i>Trypanosoma Cruzi</i>

Iván Bontempi, Pedro Fleitas, Alexia Ayelén Poato et al. · Immunotherapy · 2017 · 25 citations · Full text

Development and assessment of an improved recombinant multiepitope antigen-based immunoassay to diagnose chronic Chagas disease

Luz María Peverengo, Valeria Garcia, Luz Rodeles et al. · Parasitology · 2018 · 25 citations

Assessment of Cross-reactive Host-pathogen Antibodies in Patients With Different Stages of Chronic Chagas Disease

Miguel Hernán Vicco, Franco Ferini, Luz Rodeles et al. · Revista Española de Cardiología (English Edition) · 2013 · 20 citations · Full text

Chronic Chagas Disease, Autoimmune Disease, Humoral Response +9